← Leaderboards
Magid Abou-Gharbia
Temple Univ Of The Commonwealth
$1,840,619
Attributed
$3,681,238
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $504.4K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,681,238 · 2
By mechanism
R01$3,681,238 · 2
Top collaborators
- Jeffrey D Rothstein5 shared
- Youssef Sari4 shared
Most similar at Temple Univ Of The Commonwealth
Same institution · by research overlap
- Scott M Rawls$11,077,907
- Mary F. Morrison$5,117,685
- Yuri Persidsky$27,976,914
- Bryan D McElroy$66,057
Others in their field
Top investigators on “Scaffold”
- Vance G Fowler · Duke University$46,487,462
- Henry F Chambers · Duke University$46,487,462
- David Heimbrook · Leidos Biomedical Research, Inc.$38,175,159
- Evan Z Macosko · Broad Institute, Inc.$27,107,011
- Steven Andrew McCarroll · Broad Institute, Inc.$27,107,011
- Erich J Stafford · Center For Construction Res And Training$25,637,539
Research focus
ScaffoldRelapseDoseIn VivoNucleus AccumbensRattusBrain RegionCocaineGlutamatesIn VitroLipophilicityAnalogPharmaceutical PreparationsPropertyAntibioticsBeta-LactamsCeftriaxoneChronicAttenuatedExtracellularGlutamate TransporterHomeostasisLeadUptake
Grant awards (9)
Novel GLT-1 activators for the treatment of alcohol dependence: preclinical studies$416,030
R01 · FY2025 · AA
Novel GLT-1 activators for the treatment of alcohol dependence: preclinical studies$419,512
R01 · FY2024 · AA
Novel GLT-1 activators for the treatment of alcohol dependence: preclinical studies$430,579
R01 · FY2023 · AA
Novel GLT-1 activators for the treatment of alcohol dependence: preclinical studies$437,019
R01 · FY2022 · AA
GLT-1 Enhancers as Drug Candidates for Treating Cocaine Addiction$348,739
R01 · FY2018 · DA · contact PI
GLT-1 Enhancers as Drug Candidates for Treating Cocaine Addiction$372,311
R01 · FY2017 · DA · contact PI
GLT-1 Enhancers as Drug Candidates for Treating Cocaine Addiction$377,257
R01 · FY2016 · DA · contact PI
GLT-1 Enhancers as Drug Candidates for Treating Cocaine Addiction$375,351
R01 · FY2015 · DA · contact PI
GLT-1 Enhancers as Drug Candidates for Treating Cocaine Addiction$504,440
R01 · FY2014 · DA · contact PI